Internet-based Acceptance and Commitment Training for Elite Ice Hockey Players

March 24, 2020 updated by: Tobias Lundgren, Karolinska Institutet

Internet-based Acceptance and Commitment Training for Elite Ice Hockey Players: an Open-trial

The aim of this study is to investigate whether an internet-based psychological training program will enhance performance and affect mental health related factors in elite ice hockey players. The psychological training program is based on Acceptance and Commitment Therapy (ACT), a modern form of Cognitive Behavior Therapy, and is delivered over the internet (hence called "I-ACT"). Elite players in Sweden will be invited before the 2019/2020 season. I-ACT will start for enrolled participants during the first week of October 2019 (30th September- 2nd October depending on the schedule of the particular league; approximately 5 games have then been played in the leagues eligible for participation). I-ACT consists of seven weekly modules/chapters with ACT content and participants also have a psychological trainer in the program that they can contact via a chat function on the web platform. Participants will have completed I-ACT the 17th of November 2019. When I-ACT starts in October, other eligible players will have the opportunity to leave their notice of interest for participation in the study and to take part of I-ACT in a later stage of the season. This concurrent "waiting list" is not a waiting list control group in any sense. It only gives further eligible players the opportunity to enroll in the study for a consecutive start of the psychological training program. I-ACT will start for this second group of players during the last week in november (25th November 2019), and finish I-ACT the 12th January 2020. These two consecutive groups of I-ACT participants will be considered the experimental group. However, due to the length of the ice hockey season the second group will only have follow-up measurements at 1 month for female players (the women's league ends in February 2020) and 2 months for male players (the men's leagues ends in March 2020). Official statistics will be collected from the leagues and enrolled participants will be compared to non-participant players in the leagues to compare the effectiveness of I-ACT on ice hockey performance. Only within-group comparisons will be made for secondary outcome measures.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
57

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Sweden
    • Stockholm County
      • Stockholm, Stockholm County, Sweden, 11364
        • Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Playing ice hockey on elite level in any of the following leagues: Svenska damhockeyligan (SDHL, the Swedish premier ice hockey league for women), Svenska hockeyligan (SHL, the Swedish premier ice hockey league for men), Hockeyallsvenskan (the Swedish second highest league in ice hockey for men).

Exclusion Criteria:

  • Players currently participating in any other individual psychological training program.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: I-ACT
I-ACT is short for Internet-Acceptance and Commitment Training
Behavioral: I-ACT
An internet-based behavioral psychotherapy intervention to enhance athletic performance in elite ice hockey players.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Objective ice hockey performance data: goals
Time Frame: Pre (aggr. to a single score from 5 games pre),during(aggr. to single scores from 5 game intervals until end of interv),post(aggr. to a single score from 5 games post), followup(aggr. to single scores from 5 game intervals up to 4-16 weeks = season ends)
Scored goals by a player. Data is always aggregated from a 5 game interval into a single score. The statistics will be collected by the official statistic systems for eligible leagues, which in turn will be used in the study.
Pre (aggr. to a single score from 5 games pre),during(aggr. to single scores from 5 game intervals until end of interv),post(aggr. to a single score from 5 games post), followup(aggr. to single scores from 5 game intervals up to 4-16 weeks = season ends)
Objective ice hockey performance data: assists
Time Frame: Pre (aggr. to a single score from 5 games pre),during(aggr. to single scores from 5 game intervals until end of interv),post(aggr. to a single score from 5 games post), followup(aggr. to single scores from 5 game intervals up to 4-16 weeks = season ends)
Made assists by a player. Data is always aggregated from a 5 game interval into a single score. The statistics will be collected by the official statistic systems for eligible leagues, which in turn will be used in the study.
Pre (aggr. to a single score from 5 games pre),during(aggr. to single scores from 5 game intervals until end of interv),post(aggr. to a single score from 5 games post), followup(aggr. to single scores from 5 game intervals up to 4-16 weeks = season ends)
Objective ice hockey performance data: total points
Time Frame: Pre (aggr. to a single score from 5 games pre),during(aggr. to single scores from 5 game intervals until end of interv),post(aggr. to a single score from 5 games post), followup(aggr. to single scores from 5 game intervals up to 4-16 weeks = season ends)
Total points by a player (number of goals + assists). Data is always aggregated from a 5 game interval into a single score. The statistics will be collected by the official statistic systems for eligible leagues, which in turn will be used in the study.
Pre (aggr. to a single score from 5 games pre),during(aggr. to single scores from 5 game intervals until end of interv),post(aggr. to a single score from 5 games post), followup(aggr. to single scores from 5 game intervals up to 4-16 weeks = season ends)
Objective ice hockey performance data: +/- statistics
Time Frame: Pre (aggr. to a single score from 5 games pre),during(aggr. to single scores from 5 game intervals until end of interv),post(aggr. to a single score from 5 games post), followup(aggr. to single scores from 5 game intervals up to 4-16 weeks = season ends)
+/- statistics for a player (number of goals scored and conceded by a team while a certain player is on the ice) . Data is always aggregated from a 5 game interval into a single score. The statistics will be collected by the official statistic systems for eligible leagues, which in turn will be used in the study.
Pre (aggr. to a single score from 5 games pre),during(aggr. to single scores from 5 game intervals until end of interv),post(aggr. to a single score from 5 games post), followup(aggr. to single scores from 5 game intervals up to 4-16 weeks = season ends)
Objective ice hockey performance data: saving percent (only for goalkeepers)
Time Frame: Pre (aggr. to a single score from 5 games pre),during(aggr. to single scores from 5 game intervals until end of interv),post(aggr. to a single score from 5 games post), followup(aggr. to single scores from 5 game intervals up to 4-16 weeks = season ends)
Saving percent (only for goalkeepers). Data is always aggregated from a 5 game interval into a single score. The statistics will be collected by the official statistic systems for eligible leagues, which in turn will be used in the study.
Pre (aggr. to a single score from 5 games pre),during(aggr. to single scores from 5 game intervals until end of interv),post(aggr. to a single score from 5 games post), followup(aggr. to single scores from 5 game intervals up to 4-16 weeks = season ends)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
The Values, Acceptance and Mindfulness Scale for Ice Hockey (VAMS)
Time Frame: Pre-intervention, during(every week for the 7 week interv), post-intervention, and follow up at every 4th week until end of season (up to 4-16 weeks depending on the participants league and if the player is enrolled in the first or second start of I-ACT)
Measures behavioral and psychological flexibility in ice hockey. 11 items. Total range is 11-77. A high value represent a better outcome. Three subscales; Acceptance (5 items, points range 1-35); Values (3 items, points range 1-21); Mindfulness (3 items, points range 1-21). The subscale scores are summed for total score.
Pre-intervention, during(every week for the 7 week interv), post-intervention, and follow up at every 4th week until end of season (up to 4-16 weeks depending on the participants league and if the player is enrolled in the first or second start of I-ACT)
Subjective performance
Time Frame: Pre-intervention, during(every week for the 7 week interv), post-intervention, and follow up at every 4th week until end of season (up to 4-16 weeks depending on the participants league and if the player is enrolled in the first or second start of I-ACT)
Players subjective rating of performance. This is a single-item measure developed for this study asking players to rate their own hockey performance during the last week on a scale of 1-10 (1 = extremely poor, 10 = extremely good).
Pre-intervention, during(every week for the 7 week interv), post-intervention, and follow up at every 4th week until end of season (up to 4-16 weeks depending on the participants league and if the player is enrolled in the first or second start of I-ACT)
Brunnsviken Brief Quality of Life Scale (BBQ)
Time Frame: Pre-intervention, during intervention (at week 4), post-intervention, and follow up at every 4th week until end of season (up to 4-16 weeks depending on the participants league and if the player is enrolled in the first or second start of I-ACT)
Measures quality of life. 12 items. Total range is 0-96. A higher value is the better outcome.
Pre-intervention, during intervention (at week 4), post-intervention, and follow up at every 4th week until end of season (up to 4-16 weeks depending on the participants league and if the player is enrolled in the first or second start of I-ACT)
Insomnia Severity Index (ISI)
Time Frame: Pre-intervention, during intervention (at week 4), post-intervention, and follow up at every 4th week until end of season (up to 4-16 weeks depending on the participants league and if the player is enrolled in the first or second start of I-ACT)
Measures sleep impairment and quality
Pre-intervention, during intervention (at week 4), post-intervention, and follow up at every 4th week until end of season (up to 4-16 weeks depending on the participants league and if the player is enrolled in the first or second start of I-ACT)
General Anxiety Disorder 7-item Scale
Time Frame: Pre-intervention, post-intervention, and follow up at every 4th week until end of season (up to 4-16 weeks depending on the participants league and if the player is enrolled in the first or second start of I-ACT)
Measures generalised anxiety. 7 items. Total range is 0-21. A low value is the better outcome.
Pre-intervention, post-intervention, and follow up at every 4th week until end of season (up to 4-16 weeks depending on the participants league and if the player is enrolled in the first or second start of I-ACT)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Karolinska Institutet

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 9, 2019

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 12, 2020

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 12, 2020

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
September 23, 2019

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 27, 2019

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
September 30, 2019

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 25, 2020

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 24, 2020

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • I-ACT-Hockey

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings